Published date: 14 March 2019
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Financial consultancy services - 66171000
Location of contract
North East
Value of contract
£30,000
Procurement reference
NCL001-DN391435-97745755
Published date
14 March 2019
Closing date
18 February 2019
Contract start date
7 March 2019
Contract end date
31 July 2019
Contract type
Service contract
Procedure type
Open procedure
Any interested supplier may submit a tender in response to an opportunity notice.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Professor Che Connon and Dr Martina Miotto of Newcastle University, have developed revolutionary technologies to increase the efficiency and scalability of in vitro cultured adherent cells. The unique technology facilitates the culture of cells in serum-free medium whilst also providing an innovative system for the continuous manufacture of adherent cells. In particular, two products will be developed: i) a stable peptide-based coating that increases the proliferation rate of adherent cells under serum-free conditions in both static and dynamic conditions; ii) the world first continuous bioreactor capable of the unremitting production of cells via controlling adhesion and self-detachment of cells from a smart lipopeptidic coating. The advantages of continuous bioprocessing in adherent cell production versus a batch process (which has remained fundamentally unchanged for the last 100 years) are numerous (e.g. reduction of footprint, resources and costs), however there are no available commercial technologies that employ this approach to cell manufacture. Thus, our innovative technology is very relevant to companies culturing either a high number or precise form of adherent cell, since it will not only reduce overall costs of manufacture (or allowing several magnitudes of more cells produced at the same cost) but also ameliorate variance in product quality and reproducibility. Target markets for this technology include viral vector manufacturing and cell-based meat manufacturing.
The prospective company creation is quite advanced with potential customers and investors in place and customer development projects agreed. Moreover CellulaREvolution has recently been granted a competitive grant from InnovateUK to create the company and pay salaries of key staff including CEO.
Award information
Awarded date
7 March 2019
Contract start date
8 March 2019
Contract end date
31 July 2019
Total value of contract
£30,000
This contract was awarded to 1 supplier.
Leo Groenewegen / Kipper Ventures
Address
Valhallavägen
14 lgh 1104
Stockholm
11422
SwedenReference
None
Supplier is SME?
Yes
Supplier is VCSE?
No
About the buyer
Contact name
Natalie Morton
Address
Newcastle University
Procurement Services, Kingsgate
Newcastle
NE1 7RU
United Kingdom
Telephone
+44 1912086396
Website
Share this notice
Closing: 18 February 2019
All content is available under the
